CEACAM5 and neoplasm: Although several studies have investigated the usefulness of serum biomarkers, including carcinoembryonic antigen [28], CYFRA 21–1 [29], microRNAs [30], and circulating tumor cells [31], for the prognosis of CC patients after RT, as yet there are no established biomarkers.